GLOW

Description

GLOW 70 – GHK-Cu (50mg) / BPC-157 (10mg) / TB-500 (10mg)

Reagent Grade Peptide Research Blend

Product Description

---

What is GLOW 70 (GHK-Cu / BPC-157 / TB-500)?

GLOW 70 is a tri-peptide complex designed for advanced regenerative and cellular repair research. It combines three distinct, well-characterized synthetic peptides : GHK-Cu, BPC-157, and TB-500 that have been individually studied for their effects on tissue regeneration, inflammation modulation, and wound healing.

This blend enables researchers to explore synergistic cellular pathways that support angiogenesis, fibroblast activity, actin modulation, and tissue recovery across multiple experimental models.

Chemical Structure / Composition

• GHK-Cu (Gly-His-Lys-Copper Complex) – A naturally occurring copper-binding tripeptide that plays a key role in cellular communication and tissue repair.

• BPC-157 – A synthetic pentadecapeptide derived from human gastric juice, known to stimulate fibroblast proliferation, angiogenesis, and mucosal regeneration.

• TB-500 (Thymosin Beta-4 Fragment) – A 43-amino-acid peptide that modulates actin cytoskeleton dynamics, enhances cell migration, and accelerates wound healing in research models.

Each peptide is produced under strict reagent-grade conditions, ensuring consistency, purity, and reproducibility for in-vitro and in-vivo scientific studies.

Mechanism of Action

The GLOW 70 complex operates through multi-pathway biological signaling:

• GHK-Cu activates regenerative gene expression and supports antioxidant enzyme systems, restoring oxidative stress-induced damage.

• BPC-157 enhances angiogenesis, fibroblast activity, and epithelial repair by modulating growth factor pathways.

• TB-500 regulates actin polymerization, facilitating cellular migration and structural remodeling during tissue recovery.

Together, these peptides exhibit potential synergistic effects in tissue regeneration, wound healing, and inflammation modulation under controlled experimental conditions.

Research Applications

• Tissue regeneration and wound repair models

• Fibroblast proliferation and angiogenesis studies

• Cellular migration and actin regulation assays

• Anti-inflammatory and oxidative stress modulation research

• Collagen remodeling and skin rejuvenation studies

Safety & Tolerability

Each component of GLOW 70 has demonstrated favorable safety and stability profiles in preclinical research. The formulation is non-cytotoxic when used under standard laboratory conditions.
⚠️ For laboratory research use only. Not for human or veterinary use. Handle with appropriate laboratory safety protocols.

Supporting Literature

1. PubChem Compound Summary for GHK (CID 21350): Gly-His-Lys tripeptide copper complex GHK-Cu.

2. Chai Y, Kim B, Lee K, et al. GHK-Cu restores oxidative stress–induced damage via antioxidant enzyme activation in vitro. Cosmetics. 2015;2(3):236–247.

3. Mao S, Huang J, et al. GHK-Cu promotes mucosal healing via SIRT1/STAT3 modulation in DSS colitis. Front Pharmacol. 2025;16:1551843.

4. Huang T, et al. Body protective compound-157 enhances alkali-burn wound healing and angiogenesis in vitro and in vivo. Drug Des Devel Ther. 2015;9:2485–2499.

5. Pledger WJ, Wang X, Romeo G, Raines EW. Thymosin β-4 enhances endothelial cell migration via actin regulation. Wound Repair Regen.

Third Party Verified

70 MG – GL0812J – 09/02/2025 – Purity + Endotoxin